IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.
about
IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@en
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@nl
type
label
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@en
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@nl
prefLabel
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@en
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@nl
P2093
P2860
P356
P1476
IKAROS expression in distinct ...... e therapy in multiple myeloma.
@en
P2093
Adalbert Weißmann
Alberto Rocci
Arnold Bolomsky
Daniel Heintel
Ercan Müldür
Karin Schlangen
Martin Willheim
Niklas Zojer
Stefano Spada
Veronique Fritz
P2860
P304
P356
10.1002/AJH.24634
P577
2017-01-04T00:00:00Z